This is a recording from the Cardiomyopathy UK 2022 Conference.
Our conferences bring together leading cardiomyopathy clinicians to present and respond to audience questions.
In this video, Professor Perry Elliot - President of Cardiomyopathy UK, discusses Hypertrophic Cardiomyopathy (HCM) and Hypertrophic obstructive Cardiomyopathy (HoCM).
Key topics:
00:00:55 – What is hypertrophic cardiomyopathy?
00:09:58 – How many people are affected by hypertrophic cardiomyopathy?
00:11:45 – How is hypertrophic cardiomyopathy diagnosed?
00:16:42 – What is the impact of hypertrophic cardiomyopathy?
00:19:44 – What is the management for hypertrophic cardiomyopathy?
00:22:58 – What is an ICD / S-ICD?
00:25:31 – What is the risk of sudden cardiac death?
00:28:21 – What is left ventricular outflow tract obstruction?
00:31:08 - Disopyramide
00:32:57 – What are the surgical interventions for hypertrophic cardiomyopathy?
00:35:48 – What is Mavacamten?
00:37:31 – What is the stroke risk in hypertrophic cardiomyopathy?
00:39:58 – What is heart failure?
Audience questions:
00:43:00 – Should treatment of stroke be the same for people with HoCM as the general population?
00:44:18 – What is ‘Widowmaker Syndrome'?
00:44:47 – Why is the risk of sudden cardiac death higher in those aged 20-30 years?
00:47:48 – Can you explain the connection between heart murmur and hypertrophic cardiomyopathy?
00:49:21 – How do the American guidelines on risk differ from those in the UK?
00:54:28 – Is there a link between life events and hypertrophic cardiomyopathy?
00:56:31 – Would new drugs such as Mavacamten mean that you could have an ICD removed?
00:59:10 – Does risk of hypertrophic cardiomyopathy increase with diabetes?
00:59:41 – Why do cardiologists opinions differ in their assessment of hypertrophic cardiomyopathy?
01:05:01 – Why is asthma confused with a symptom of hypertrophic cardiomyopathy?
01:08:02 – Is Mavacamten being used in other countries? Are there trials in the UK?
01:10:54 – Is there any indication of what may put someone at risk of a stroke?
01:12:35 – Should everyone have gene testing?
01:17:53 – Should we be requesting more frequent consultations due to the rapid developments in cardiomyopathy therapies?
01:19:51 – What is the future of treatment for hypertrophic cardiomyopathy?
01:21:54 – Is the risk for males the same as females?
01:22:30 – Should very young children be genetically tested?
01:26:39 – Should I have genetic testing if there is hypertrophic cardiomyopathy in other family members?
Access free information, find out about support groups and speak with cardiomyopathy Specialist Nurses at www.cardiomyopathy.org
